Jul 2 |
Update: Novo Nordisk, Eli Lilly Charging 'Unconscionably' High Prices, Biden, Sanders Say
|
Jul 2 |
FDA approves a second Alzheimer's drug that can modestly slow disease
|
Jul 2 |
Eli Lilly Alzheimer's drug approved by US FDA
|
Jul 2 |
Eli Lilly wins FDA approval of donanemab for Alzheimer's
|
Jul 2 |
How Great Is It to Have Customers That Absolutely Love You and Plan to Never Leave You?
|
Jul 2 |
Lilly's Kisunla™ (donanemab-azbt) Approved by the FDA for the Treatment of Early Symptomatic Alzheimer's Disease
|
Jul 2 |
Eli Lilly continues radiopharma push with $140m Radionetics partnership
|
Jul 2 |
Top Midday Stories: Tesla, GM Report Vehicle Deliveries; Biden, Sanders Say Novo Nordisk, Eli Lilly Charge 'Unconscionably' High Prices; Warner Bros. Interested in Deal With Paramount
|
Jul 2 |
Novo, Lilly Fall After Biden Slams Duo For 'Unconscionably High' Drug Prices
|
Jul 2 |
Eli Lilly history: Beyond the Ticker
|